Unknown

Dataset Information

0

Investigation of Anti-Tumor Effects of an MLK1 Inhibitor in Prostate and Pancreatic Cancers.


ABSTRACT: It was shown that mixed lineage kinase 1 (MLK1) regulates pancreatic cancer growth; however, its role in prostate cancer remains unclear. We showed that MLK1 is a tumor marker in prostate cancer by analyzing clinical gene expression data and identified a novel MLK1 inhibitor (NSC14465) from the compound library of the National Cancer Institute (NCI) using a MLK1 protein structure. The inhibitory effects of MLK1 were validated by an in vitro kinase assay and by monitoring phosphorylation signaling, and the anti-proliferation function was shown in several prostate and pancreatic cancer cell lines. We also demonstrated anti-tumor ability and prevention of cancer-related weight loss in a syngeneic orthotopic mouse model of pancreatic cancer that mimicked the tumor growth environment in the pancreas. Our results demonstrate that the MLK1 inhibitor is an anti-tumor agent for malignant prostate and pancreatic cancers.

SUBMITTER: Fan YC 

PROVIDER: S-EPMC8389662 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7961597 | biostudies-literature
| S-EPMC9178990 | biostudies-literature
| S-EPMC5753661 | biostudies-literature
| S-EPMC8484793 | biostudies-literature
| S-EPMC3787053 | biostudies-literature
| S-EPMC5999272 | biostudies-literature
| S-EPMC5641089 | biostudies-other
| S-EPMC6148276 | biostudies-literature
2024-02-07 | GSE255309 | GEO
| S-EPMC8154913 | biostudies-literature